Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to 0.37.

  • Amphastar Pharmaceuticals' Debt Ratio fell 527.42% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 527.42%. This contributed to the annual value of 0.38 for FY2024, which is 216.64% down from last year.
  • Amphastar Pharmaceuticals' Debt Ratio amounted to 0.37 in Q3 2025, which was down 527.42% from 0.38 recorded in Q2 2025.
  • In the past 5 years, Amphastar Pharmaceuticals' Debt Ratio ranged from a high of 0.41 in Q3 2023 and a low of 0.06 during Q2 2021
  • Moreover, its 5-year median value for Debt Ratio was 0.36 (2023), whereas its average is 0.25.
  • Its Debt Ratio has fluctuated over the past 5 years, first tumbled by 2561.69% in 2021, then skyrocketed by 29695.21% in 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' Debt Ratio (Quarter) stood at 0.11 in 2021, then decreased by 10.78% to 0.1 in 2022, then surged by 281.32% to 0.39 in 2023, then fell by 2.17% to 0.38 in 2024, then decreased by 4.12% to 0.37 in 2025.
  • Its last three reported values are 0.37 in Q3 2025, 0.38 for Q2 2025, and 0.37 during Q1 2025.